K-V Pharmaceutical Company Announces Notification from NYSE Regarding ...
News | 30 June 2012
ST. LOUIS, June 29, 2012 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE: KVa/ KVb) (
Click on the link to read the full article at Healthcare Global (press release)
(This link will open in a new window)
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
